Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond
Open Access
- 1 October 2019
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 25 (10) , 836-852
Abstract
No abstract availableKeywords
Funding Information
- UCB
- Universitetet i Oslo
- Merck
- Norges Forskningsråd (179573/V40)
- Helse Sør-Øst RHF (2011050, 2015009)
- Chugai Pharmaceutical
This publication has 111 references indexed in Scilit:
- Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cellsNature Medicine, 2013
- Triggers and drivers of autoimmunity: lessons from coeliac diseaseNature Reviews Immunology, 2013
- Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ moleculesImmunogenetics, 2012
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2012
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialThe Lancet, 2011
- Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac DiseaseScience Translational Medicine, 2010
- Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T CellsImmunity, 2010
- Induction of Antigen-Specific Tolerance by Oral Administration of Lactococcus lactis Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab° Dq8 Transgenic MiceThe Journal of Immunology, 2009
- Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cellsJournal of Experimental Medicine, 2009
- Differential homing mechanisms regulate regionalized effector CD8αβ + T cell accumulation within the small intestineProceedings of the National Academy of Sciences, 2007